Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index; 9 of the 65 sources its claims cite were checked for support.

Suicide risk and mortality among patients with cancer

Abstract

Despite substantial progress in cancer therapy in recent decades, patients with cancer remain at high suicide risk. Data from individual studies have not been comprehensively quantified and specific risk factors are ill-defined. We assessed suicide mortality risk according to cancer prognosis, stage, time since diagnosis, gender, ethnicity, marital status, year of recruitment and geographic region. We searched EMBASE, MEDLINE, PsycINFO, Web of Science, CINAHL and Google Scholar for relevant articles up to February 2021. We used a random effects model, performed meta-regression meta-analysis and assessed heterogeneity and publication bias using I², funnel plots and Egger's and Begg's tests. We performed a systematic review including 62 studies and 46,952,813 patients. To avoid patient sample overlap, the meta-analysis was performed on 28 studies, involving 22,407,690 patients with cancer. Suicide mortality was significantly increased compared with the general population (standardized mortality ratio = 1.85, 95% confidence interval = 1.55-2.20). Risk was strongly related to cancer prognosis, cancer stage, time since diagnosis and geographic region. Patients with cancer, particularly those with specific risk factors, should be closely monitored for suicidality and need specialized care to reduce short- and long-term risks of suicide.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis found that patients with cancer had an 85% increased suicide mortality rate compared with the general population (SMR = 1.85, 95% CI = 1.55–2.20). Risk was highest among patients with poor-prognosis cancers, late-stage disease, within the first year after diagnosis, and in the USA.

Key findings

  • Overall suicide mortality was significantly increased in patients with cancer versus the general population (SMR = 1.85, 95% CI = 1.55–2.20; I² = 99.37%, P < 0.0001); a sensitivity analysis using all 62 eligible studies yielded SMR = 1.93, 95% CI = 1.71–2.18.
  • Suicide mortality differed by cancer prognosis: good prognosis SMR = 1.50 (95% CI = 1.12–2.00), intermediate prognosis SMR = 1.98 (95% CI = 1.56–2.51), and poor prognosis SMR = 3.53 (95% CI = 2.75–4.53; P for difference < 0.001).
  • Suicide mortality was higher for late-stage cancer (SMR = 3.12, 95% CI = 2.22–4.38) than early-stage cancer (SMR = 1.50, 95% CI = 1.16–1.94; P < 0.001), and higher within 1 year after diagnosis (SMR = 3.03, 95% CI = 2.09–4.39) than later than 1 year (SMR = 1.39, 95% CI = 1.12–1.72; P < 0.001).
  • Geographic region was associated with risk: USA SMR = 2.77 (95% CI = 1.62–4.74), Europe SMR = 1.51 (95% CI = 1.33–1.72), Asia SMR = 1.97 (95% CI = 1.44–2.70), Australia SMR = 1.63 (95% CI = 1.40–1.90; P for difference = 0.01). Gender, ethnicity, year of recruitment, and marital status did not reach statistical significance.

Methods

  • Systematic review and random-effects meta-analysis registered in PROSPERO (CRD42021265254); searched EMBASE, MEDLINE, PsycINFO, Web of Science, CINAHL, and Google Scholar up to February 2021, following PRISMA, MOOSE, and PRESS recommendations.
  • Included 62 cohort studies comprising 46,952,813 patients with cancer, with 69,398 suicides during at least 107,961,796 person-years; to avoid patient sample overlap, the main meta-analysis used 28 independent studies comprising 22,407,690 patients.
  • Analyzed standardized mortality ratios (SMRs) versus the general population; performed subgroup analyses and meta-regression for cancer prognosis, stage, time since diagnosis, gender, ethnicity, marital status, year of recruitment, and geographic region; assessed heterogeneity with I² and publication bias with funnel plots, Egger’s and Begg’s tests.

Limitations

  • The paper states it could not address suicidal ideations, suicide attempts, psychiatric comorbidities, depressive symptoms, psychotherapeutic care, or antidepressant therapy, because only one included study focused on suicidal thoughts and attempts and only one considered prediagnosis psychiatric care. It also could not summarize age due to overlapping age categories, could not evaluate physician-assisted death versus suicide, noted that misreporting of suicides cannot be excluded, and stated that adjustment for confounders was not homogeneous across studies.
  • The paper states that due to limited data from low-income countries, findings are primarily generalizable to high-income countries.
  • Evident from the text: heterogeneity was very high (I² ≈ 99% in main and subgroup analyses), and the authors note that heterogeneity may result from differences in cancer sites, registry documentation, and analytic strategies across primary studies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41591-022-01745-y

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

2 Valid · 2 Not valid · 30 Not checked · 106 Own results and interpretations

73 more claims

Create a free account to see all 140 claims and to verify the 56 references still open.

See all claims — free account
  • It may state two separate claims as one. 32
  • Probably not a substantial claim. 45

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 64 references

Cited by

See all 136

Metadata

Authors
Heinrich, M., Hofmann, L., Baurecht, H., Kreuzer, P. M., Knüttel, H., Leitzmann, M. F., & Seliger, C.
Affiliations
  • University of Regensburg (DE)
  • University Hospital Heidelberg (DE)
Corresponding author
Seliger, Corinna
Venue
Nature Medicine
Published
2022-03-28
Volume
28
Issue
4
Pages
852-859
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4220972327
Cited by
136
References
64
Citations by year
2026: 23 · 2025: 37 · 2024: 34 · 2023: 32 · 2022: 10
FWCI
25.78
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
  • University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
suicide risk, suicide mortality, cancer patients, standardized mortality ratio, cancer prognosis, tumor stage, time since diagnosis, regional variation, psycho-oncology, suicide prevention
MeSH terms
Humans, Neoplasms, Risk Factors, Suicide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suicide risk and mortality among patients with cancer. https://app.cochat.ai/papers/10.1038/s41591-022-01745-y
The paper
Heinrich, M., Hofmann, L., Baurecht, H., Kreuzer, P. M., Knüttel, H., Leitzmann, M. F., & Seliger, C. (2022). Suicide risk and mortality among patients with cancer. Nature Medicine. https://doi.org/10.1038/s41591-022-01745-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.